Center for Scientific Review; Notice of Closed Meetings, 100517-100518 [2024-29269]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 239 / Thursday, December 12, 2024 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2024–29160 Filed 12–11–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Health Services and Systems C.
Date: January 6, 2025.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tara Roshell Earl, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007C,
Bethesda, MD 20892, (301) 402–6857 earltr@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 9, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29287 Filed 12–11–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:28 Dec 11, 2024
Jkt 265001
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Name of Committee: Center for Scientific
Review Special Emphasis Panel RFA Panel;
Understanding Chronic Conditions
Understudied Among Women.
Date: December 13, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Amy Kathleen Wernimont,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198,
Bethesda, MD 20892, 301–827–6427,
amy.wernimont@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacterial-Host Interactions.
Date: December 13, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bakary Drammeh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 805–P,
Bethesda, MD 20892, (301) 435–0000,
drammehbs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Disease Control and
Applied Immunology.
Date: December 13, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jui Pandhare, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
100517
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–7735, pandharej2@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Topics in Microbial Diagnostics
and Anti-Infective Prevention Measures.
Date: December 13, 2024.
Time: 12:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bidyottam Mittra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20894, (301) 435–4057, bidyottam.mittra@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Health Services Research.
Date: December 18, 2024.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Angela D. Thrasher, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J,
Bethesda, MD 20892, (301) 480–6894,
thrasherad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in HIV Virology,
Immunopathogenesis, and Drug/Vaccine
Development.
Date: December 18, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kenneth M Izumi, Ph.D.,
Scientific Review Officer, NIH Center for
Scientific Review, 6701 Rockledge Drive,
MSC 7808, Bethesda, MD 20892, 301–496–
6980, izumikm@csr.nih.gov.
This notice is being published less than 15
days from the meetings’ dates due to
exceptional circumstances. The technical and
scientific peer review of applications
assigned to the above meetings must take
place urgently so that review evaluations of
biomedical research applications addressing
multiple major public health priorities,
including women’s health research, may be
submitted to the national advisory councils
to make timely funding recommendations. If
the meetings are not held on the December
13, 2024 and December 18, 2024 dates,
committee members with the requisite
scientific expertise will be unable to attend
due to unresolvable scheduling conflicts. The
result would be a 6–9 month delay in
funding and a profound negative impact on
health-related research.
E:\FR\FM\12DEN1.SGM
12DEN1
100518
Federal Register / Vol. 89, No. 239 / Thursday, December 12, 2024 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 9, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29269 Filed 12–11–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Drug discovery for
Neurodevelopmental Disorders.
Date: January 10, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lai Yee Leung, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011D,
Bethesda, MD 20892, (301) 827–8106,
leungl2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29159 Filed 12–11–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:28 Dec 11, 2024
Jkt 265001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Biomedical Research Study
Section.
Date: March 5, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mamatha Garige, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2118, Bethesda, MD 20892,
(301) 443–9737, mamatha.garige@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.273, Alcohol Research
Programs, National Institutes of Health, HHS)
Dated: December 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29161 Filed 12–11–24; 8:45 am]
BILLING CODE 4140–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Performance Review Board
Advisory Council on Historic
Preservation.
ACTION: Notice of Performance Review
Board.
AGENCY:
Appointment of individuals
to serve as members of the Performance
Review Board.
DATES: These appointments were
effective on November 27, 2024.
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Javier E. Marqués, General Counsel,
Advisory Council on Historic
Preservation, jmarques@achp.gov; 202–
517–0192.
SUPPLEMENTARY INFORMATION: The Chair
of the Advisory Council on Historic
Preservation (ACHP) has appointed the
following individuals to serve on the
ACHP’s Performance Review Board
(PRB):
Chairperson of the PRB: Amelia AM
Marchand
Member—Dr. Michael Brennan
Member—Joy Beasley
Authority: 5 U.S.C. 4314(c)(4).
Dated: December 9, 2024.
Javier E. Marqués,
General Counsel.
[FR Doc. 2024–29293 Filed 12–11–24; 8:45 am]
BILLING CODE 4310–K6–P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
[Docket No. TSA–2006–24191]
Intent To Request Extension From
OMB of One Current Public Collection
of Information: Transportation Worker
Identification Credential (TWIC®)
Program
Transportation Security
Administration, DHS.
ACTION: 60-Day notice.
AGENCY:
The Transportation Security
Administration (TSA) invites public
comment on one currently approved
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0047,
abstracted below that we will submit to
OMB for an extension, in compliance
with the Paperwork Reduction Act
(PRA). The ICR describes the nature of
the information collection and its
expected burden. The collection
involves the submission of biographic
and biometric information that TSA
uses to verify identity and conduct a
security threat assessment (STA) for the
Transportation Worker Identification
Credential (TWIC®) Program, and a
customer satisfaction survey.
DATES: Send your comments by
February 10, 2025.
ADDRESSES: Comments may be emailed
to TSAPRA@tsa.dhs.gov or delivered to
the TSA PRA Officer, Information
Technology (IT), TSA–11,
Transportation Security Administration,
6595 Springfield Center Drive,
Springfield, VA 20598–6011.
SUMMARY:
E:\FR\FM\12DEN1.SGM
12DEN1
]]>Agencies
[Federal Register Volume 89, Number 239 (Thursday, December 12, 2024)]
[Notices]
[Pages 100517-100518]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29269]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel RFA Panel; Understanding Chronic Conditions Understudied Among
Women.
Date: December 13, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Amy Kathleen Wernimont, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198, Bethesda, MD 20892, 301-
827-6427, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Bacterial-Host Interactions.
Date: December 13, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bakary Drammeh, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 805-P, Bethesda, MD 20892, (301)
435-0000, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Disease Control and Applied
Immunology.
Date: December 13, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jui Pandhare, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 594-7735,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Topics in Microbial Diagnostics and Anti-
Infective Prevention Measures.
Date: December 13, 2024.
Time: 12:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bidyottam Mittra, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20894, (301) 435-4057,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Health Services Research.
Date: December 18, 2024.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Angela D. Thrasher, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J, Bethesda, MD 20892, (301)
480-6894, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in HIV Virology, Immunopathogenesis,
and Drug/Vaccine Development.
Date: December 18, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kenneth M Izumi, Ph.D., Scientific Review
Officer, NIH Center for Scientific Review, 6701 Rockledge Drive, MSC
7808, Bethesda, MD 20892, 301-496-6980, [email protected].
This notice is being published less than 15 days from the
meetings' dates due to exceptional circumstances. The technical and
scientific peer review of applications assigned to the above
meetings must take place urgently so that review evaluations of
biomedical research applications addressing multiple major public
health priorities, including women's health research, may be
submitted to the national advisory councils to make timely funding
recommendations. If the meetings are not held on the December 13,
2024 and December 18, 2024 dates, committee members with the
requisite scientific expertise will be unable to attend due to
unresolvable scheduling conflicts. The result would be a 6-9 month
delay in funding and a profound negative impact on health-related
research.
[[Page 100518]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: December 9, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-29269 Filed 12-11-24; 8:45 am]
BILLING CODE 4140-01-P
